High-dose interleukin-2 therapy for metastatic renal cell carcinoma: a contemporary experience.
Hanzly M, Aboumohamed A, Yarlagadda N, Creighton T, Digiorgio L, Fredrick A, Rao G, Mehedint D, George S, Attwood K, Kauffman E, Narashima D, Khushalani NI, Pili R, Schwaab T.
Hanzly M, et al.
Urology. 2014 May;83(5):1129-34. doi: 10.1016/j.urology.2014.02.005.
Urology. 2014.
PMID: 24767525